HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 190 filers reported holding HERON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $387,466 | -37.5% | 256,600 | +3.6% | 0.00% | – |
| Q4 2022 | $619,500 | -47.3% | 247,800 | -11.1% | 0.00% | -100.0% |
| Q3 2022 | $1,176,000 | +75.0% | 278,700 | +15.8% | 0.00% | – |
| Q2 2022 | $672,000 | -48.7% | 240,700 | +5.1% | 0.00% | -100.0% |
| Q1 2022 | $1,310,000 | -32.9% | 229,000 | +7.2% | 0.00% | 0.0% |
| Q4 2021 | $1,951,000 | -14.6% | 213,700 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $2,284,000 | -23.1% | 213,700 | +11.7% | 0.00% | -50.0% |
| Q2 2021 | $2,971,000 | -7.1% | 191,400 | -2.9% | 0.00% | 0.0% |
| Q1 2021 | $3,197,000 | -22.6% | 197,200 | +1.0% | 0.00% | -33.3% |
| Q4 2020 | $4,131,000 | +42.8% | 195,200 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $2,893,000 | +3.0% | 195,200 | +2.2% | 0.00% | 0.0% |
| Q2 2020 | $2,810,000 | +44.3% | 191,000 | +15.1% | 0.00% | 0.0% |
| Q1 2020 | $1,948,000 | -48.5% | 165,900 | +3.2% | 0.00% | -50.0% |
| Q4 2019 | $3,779,000 | +44.7% | 160,800 | +13.9% | 0.00% | +33.3% |
| Q3 2019 | $2,612,000 | +1.7% | 141,200 | +2.2% | 0.00% | 0.0% |
| Q2 2019 | $2,569,000 | -17.9% | 138,200 | +8.0% | 0.00% | 0.0% |
| Q1 2019 | $3,128,000 | -2.5% | 128,000 | +3.5% | 0.00% | -25.0% |
| Q4 2018 | $3,209,000 | -10.3% | 123,700 | +9.5% | 0.00% | 0.0% |
| Q3 2018 | $3,576,000 | -8.2% | 113,000 | +12.7% | 0.00% | 0.0% |
| Q2 2018 | $3,897,000 | +40.8% | 100,300 | 0.0% | 0.00% | +33.3% |
| Q1 2018 | $2,768,000 | +55.2% | 100,300 | +1.8% | 0.00% | +50.0% |
| Q4 2017 | $1,783,000 | +40.6% | 98,500 | +25.5% | 0.00% | +100.0% |
| Q3 2017 | $1,268,000 | +16.7% | 78,500 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,087,000 | -0.2% | 78,500 | +8.1% | 0.00% | 0.0% |
| Q1 2017 | $1,089,000 | +60.1% | 72,600 | +39.9% | 0.00% | 0.0% |
| Q4 2016 | $680,000 | -23.9% | 51,900 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $894,000 | -4.6% | 51,900 | 0.0% | 0.00% | -50.0% |
| Q2 2016 | $937,000 | +1.3% | 51,900 | +3.0% | 0.00% | 0.0% |
| Q1 2016 | $925,000 | -15.9% | 50,400 | +22.3% | 0.00% | -33.3% |
| Q4 2015 | $1,100,000 | – | 41,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |